Related Experiment Videos
The effect of alpha-MSH on plasma growth hormone, cortisol and TSH in children
Insights
Synthetic alpha-melanocyte-stimulating hormone (alpha-MSH) showed a growth hormone (GH) response in some children with hypopituitarism. Alpha-MSH also increased cortisol levels, suggesting a potential adrenal-stimulating effect.
Area of Science:
- Pediatric Endocrinology
- Hormone Research
Background:
- Synthetic alpha-melanocyte-stimulating hormone (alpha-MSH) is a peptide hormone with potential regulatory roles.
- Investigating the effects of alpha-MSH in pediatric endocrine disorders is crucial for understanding hormone interactions.
Purpose of the Study:
- To evaluate the effects of intravenous synthetic alpha-MSH on growth hormone (GH) and cortisol levels in prepubertal children.
- To explore the potential of alpha-MSH as a diagnostic or therapeutic agent in pediatric endocrine conditions.
Main Methods:
- Intravenous administration of synthetic alpha-MSH (3 mg dose) to 19 prepubertal children.
- Assessed growth hormone (GH) response in children with constitutional short stature and hypopituitarism.
- Measured plasma cortisol, thyroid-stimulating hormone (TSH), and blood glucose levels before and after alpha-MSH injection.
Main Results:
- A significant growth hormone (GH) response to alpha-MSH was observed in 2 of 8 constitutionally small children and unexpectedly in 3 of 11 children with hypopituitarism (all with craniopharyngiomas).
- Plasma cortisol increased in most children following alpha-MSH administration, comparable to insulin-induced increases but without hypoglycemia or stress.
- No significant effects of alpha-MSH were noted on plasma TSH or blood glucose levels.
Conclusions:
- Synthetic alpha-MSH may stimulate GH release in specific pediatric populations, particularly those with hypopituitarism and craniopharyngiomas.
- Alpha-MSH appears to directly stimulate the adrenal glands, increasing cortisol production in an ACTH-like manner.
- Further research is warranted to elucidate the precise mechanisms and clinical applications of alpha-MSH in pediatric endocrinology.
Abstract:
The effect of synthetic alpha-MSH injected intravenously in a uniform dose of 3 mg was studied in 19 prepubertal children. A marked growth hormone (GH) response was seen only in 2 out of 8 constitutionally small children with a normal GH response to insulin and arginine stimulation. Three of of 11 children suffering from hypopituitarism with documented GH and other hormone deficiencies, unexpectedly, showed a significant rise of GH after alpha-MSH: all three had craniopharyngiomas. Alpha-MSH led to an increase of plasma cortisol in all except 3 patients who had secondary adrenal insuffciency. The increase of cortisol after alpha-MSH and after insulin was of the same extent: but the hypoglycemia and stress responsible for the insulin effect were not observed after alpha-MSH. It is possible that alpha-MSH acts by an ACTH-like direct stimulation on the adrenals. There was no effect of alpha-MSH on plasma TSH or on blood glucose.